MFCM
NAGE

Mercator Fund (Cayman Master)’s Niagen Bioscience NAGE Stock Holding History

Mercator Fund (Cayman Master)’s Portfolio NAGE Stock Details NAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$1.36M Buy
+315,025
New +$1.12M 1.08% 13

Other funds holding NAGE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return
TCM
Tieton Capital Management Yakima, Washington $299M AUM 54.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UIC
Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SA
Sycale Advisors New York $201M AUM 2.35% 1-Year Est. Return
JMPWA
JP Morgan Private Wealth Advisors San Francisco, California $35B AUM 24.26% 1-Year Est. Return

Mercator Fund (Cayman Master)'s NAGE Position: Q4 2019 in Review

Mercator Fund (Cayman Master) opened a new position in Niagen Bioscience (NAGE) in Q4 2019: 315,025 shares worth $1.36M. The stake represents 1.08% of the portfolio and ranks #13 among its holdings.

65 funds tracked by Wall St. Rank hold NAGE as of Q4 2019.

  • Mercator Fund (Cayman Master) held 315,025 shares of Niagen Bioscience worth $1.36M as of Q4 2019.
  • Niagen Bioscience was a new Mercator Fund (Cayman Master) position in Q4 2019.
  • Niagen Bioscience made up 1.08% of Mercator Fund (Cayman Master)'s portfolio in Q4 2019, its #13 holding.
  • 65 funds tracked by Wall St. Rank held Niagen Bioscience as of Q4 2019.

Based on Mercator Fund (Cayman Master)'s 13F filing for Q4 2019, filed 21 Jan 2020.